ADVM
Price
$2.63
Change
-$0.10 (-3.66%)
Updated
Jul 15 closing price
Capitalization
54.94M
CNTX
Price
$0.72
Change
-$0.01 (-1.37%)
Updated
Jul 15, 04:59 PM (EDT)
Capitalization
65.96M
21 days until earnings call
Interact to see
Advertisement

ADVM vs CNTX

Header iconADVM vs CNTX Comparison
Open Charts ADVM vs CNTXBanner chart's image
Adverum Biotechnologies
Price$2.63
Change-$0.10 (-3.66%)
Volume$112.71K
Capitalization54.94M
Context Therapeutics
Price$0.72
Change-$0.01 (-1.37%)
Volume$410
Capitalization65.96M
ADVM vs CNTX Comparison Chart in %
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. CNTX commentary
Jul 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a Buy and CNTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 16, 2025
Stock price -- (ADVM: $2.63 vs. CNTX: $0.74)
Brand notoriety: ADVM and CNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 36% vs. CNTX: 106%
Market capitalization -- ADVM: $54.94M vs. CNTX: $65.96M
ADVM [@Biotechnology] is valued at $54.94M. CNTX’s [@Biotechnology] market capitalization is $65.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileCNTX’s FA Score has 0 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • CNTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ADVM and CNTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 4 TA indicator(s) are bullish while CNTX’s TA Score has 4 bullish TA indicator(s).

  • ADVM’s TA Score: 4 bullish, 4 bearish.
  • CNTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ADVM is a better buy in the short-term than CNTX.

Price Growth

ADVM (@Biotechnology) experienced а +9.58% price change this week, while CNTX (@Biotechnology) price change was +14.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.69%. For the same industry, the average monthly price growth was +18.51%, and the average quarterly price growth was +31.06%.

Reported Earning Dates

ADVM is expected to report earnings on Apr 15, 2025.

CNTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CNTX($66M) has a higher market cap than ADVM($54.9M). CNTX YTD gains are higher at: -29.971 vs. ADVM (-43.683). CNTX has higher annual earnings (EBITDA): -31.62M vs. ADVM (-154.84M). CNTX has more cash in the bank: 89.4M vs. ADVM (83.1M). CNTX has less debt than ADVM: CNTX (194K) vs ADVM (93.2M). ADVM has higher revenues than CNTX: ADVM (1M) vs CNTX (0).
ADVMCNTXADVM / CNTX
Capitalization54.9M66M83%
EBITDA-154.84M-31.62M490%
Gain YTD-43.683-29.971146%
P/E RatioN/AN/A-
Revenue1M0-
Total Cash83.1M89.4M93%
Total Debt93.2M194K48,041%
FUNDAMENTALS RATINGS
ADVM: Fundamental Ratings
ADVM
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADVMCNTX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 6 days ago
79%
Bullish Trend 9 days ago
87%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIXN0.10N/A
N/A
AiXin Life International, Inc.
TNISF19.00N/A
N/A
Tecnicas Reunidas Sa
HAWLL13.20N/A
N/A
Hawaiian Electric Co., Inc.
TRYIY13.44-0.10
-0.74%
Toray Industries Inc.
VSBGF0.07-0.01
-7.59%
VSBLTY GROUPE TECHNOLOGIES CORP.

ADVM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADVM has been loosely correlated with CCCC. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ADVM jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADVM
1D Price
Change %
ADVM100%
-3.66%
CCCC - ADVM
47%
Loosely correlated
-11.34%
XENE - ADVM
45%
Loosely correlated
-3.44%
OCUL - ADVM
45%
Loosely correlated
-1.60%
XNCR - ADVM
45%
Loosely correlated
-4.63%
IDYA - ADVM
45%
Loosely correlated
-5.09%
More

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and OBIO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and OBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
+0.42%
OBIO - CNTX
30%
Poorly correlated
-3.63%
ABSI - CNTX
30%
Poorly correlated
-3.38%
ADVM - CNTX
29%
Poorly correlated
-3.66%
CMMB - CNTX
29%
Poorly correlated
-1.71%
IPSC - CNTX
29%
Poorly correlated
-3.58%
More